US Tech 100

19,436.00

-0.73%

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

SRZN Surrozen Inc

10.2499

-0.0801 (-0.78%)

Sep 27 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Surrozen (NASDAQ:SRZN)
Historical Stock Chart
From Aug 2024 to Sep 2024

Surrozen (NASDAQ:SRZN)
Historical Stock Chart
From Sep 2023 to Sep 2024

Surrozen Inc News

Surrozen Earns $10 Million Milestone Payment in Retinal Diseases Collaboration
Tuesday 24 September 2024 (5 days ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Monday 12 August 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Monday 12 August 2024 (2 months ago) • Edgar (US Regulatory)

Surrozen Provides Second Quarter 2024 Financial Results and Business Update
Monday 12 August 2024 (2 months ago) • GlobeNewswire Inc.

Surrozen Publishes Study in ‘eLife’ Demonstrating the Promise of The Proprietary SWEETS Platform, a Unique Targeted Protein Degradation Technology, to Further Enhance Wnt Signaling
Wednesday 12 June 2024 (4 months ago) • GlobeNewswire Inc.

Surrozen Presents Preliminary Results from Phase 1a Study of SZN-043 in Healthy Volunteers and Patients with a History of Liver Cirrhosis at the 2024 European Association for the Study of the Liver (EASL) in Milan
Monday 10 June 2024 (4 months ago) • GlobeNewswire Inc.

Surrozen Initiates Dosing of First Patient in Phase 1b Clinical Trial of SZN-043 for Severe Alcohol-Associated Hepatitis
Tuesday 4 June 2024 (4 months ago) • GlobeNewswire Inc.

Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea Endothelial Dystrophies and Dry Eye Disease at the Associations for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Thursday 9 May 2024 (5 months ago) • GlobeNewswire Inc.

Surrozen Provides First Quarter 2024 Financial Results and Business Update
Wednesday 8 May 2024 (5 months ago) • GlobeNewswire Inc.

Surrozen Publishes Study in 'Respiratory Research' Demonstrating the Promise of a Wnt Mimetic Antibody in Treating Pulmonary Fibrosis
Wednesday 3 April 2024 (6 months ago) • GlobeNewswire Inc.

Surrozen Announces Safety, Pharmacodynamic and Liver Function Data for SZN-043
Monday 1 April 2024 (6 months ago) • GlobeNewswire Inc.

Surrozen Announces up to $192.5 Million Private Placement of Securities Priced At-the-Market Under Nasdaq Rules
Monday 1 April 2024 (6 months ago) • GlobeNewswire Inc.

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

SRZN Surrozen Inc

Surrozen Inc News

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

SRZN Surrozen Inc

Surrozen Inc News

Your Recent History

Company

Business

Popular

Get The App